These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27260130)

  • 21. Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study.
    Hadgraft J; Whitefield M; Rosher PH
    Skin Pharmacol Appl Skin Physiol; 2003; 16(3):137-42. PubMed ID: 12677093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of layered application on the skin permeation of a cosmetic active component, rhododendrol.
    Arce FV; Asano N; Yamashita K; Oda A; Uchida T; Sano T; Todo H; Sugibayashi K
    J Toxicol Sci; 2019; 44(1):1-11. PubMed ID: 30626775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of chemical absorption into and through the skin from cosmetic and dermatological formulations.
    Grégoire S; Ribaud C; Benech F; Meunier JR; Garrigues-Mazert A; Guy RH
    Br J Dermatol; 2009 Jan; 160(1):80-91. PubMed ID: 18811683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blanching activities of betamethasone formulations. The effect of dosage form on topical drug availability.
    Smith EW; Meyer E; Haigh JM
    Arzneimittelforschung; 1990 May; 40(5):618-21. PubMed ID: 2383308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New easy handling and sampling device for bioavailability screening of topical formulations.
    Salmon D; Gilbert E; Gioia B; Haftek M; Pivot C; Verrier B; Pirot F
    Eur J Dermatol; 2015 Apr; 25 Suppl 1():23-9. PubMed ID: 26083671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of the in vitro permeation of ibuprofen in mammalian skin, the PAMPA model and silicone membrane.
    Luo L; Patel A; Sinko B; Bell M; Wibawa J; Hadgraft J; Lane ME
    Int J Pharm; 2016 May; 505(1-2):14-9. PubMed ID: 27025294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
    Pardeike J; Hommoss A; Müller RH
    Int J Pharm; 2009 Jan; 366(1-2):170-84. PubMed ID: 18992314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cream formulation impact on topical administration of engineered colloidal nanoparticles.
    Santini B; Zanoni I; Marzi R; Cigni C; Bedoni M; Gramatica F; Palugan L; Corsi F; Granucci F; Colombo M
    PLoS One; 2015; 10(5):e0126366. PubMed ID: 25962161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of bioavailability: measurement of absorption through skin in vitro.
    Hotchkiss SA
    Curr Protoc Toxicol; 2001 May; Chapter 5():Unit 5.1.1-14. PubMed ID: 20949434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
    Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
    J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymeric and lipid-based materials for topical nanoparticle delivery systems.
    Pawar KR; Babu RJ
    Crit Rev Ther Drug Carrier Syst; 2010; 27(5):419-59. PubMed ID: 21083529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug delivery to and through the skin.
    Guy RH
    Drug Deliv Transl Res; 2024 Aug; 14(8):2032-2040. PubMed ID: 38837116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and characterization of new and scalable topical formulations containing N-acetyl-d-glucosamine-loaded solid lipid nanoparticles.
    Marto J; Sangalli C; Capra P; Perugini P; Ascenso A; Gonçalves L; Ribeiro H
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1792-1800. PubMed ID: 28581831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous absorption.
    Brisson P
    Can Med Assoc J; 1974 May; 110(10):1182-5. PubMed ID: 4597976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyoxyethylene fatty acid esters as potential promotors of transdermal absorption for morphine hydrochloride and sulphate.
    Samczewska G; Piechota-Urbańska M; Kołodziejska J
    Polim Med; 2006; 36(2):17-32. PubMed ID: 17022153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical delivery of acyclovir and ketoconazole.
    Jacobs GA; Gerber M; Malan MM; du Preez JL; Fox LT; du Plessis J
    Drug Deliv; 2016; 23(2):631-41. PubMed ID: 25005585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metamorphosis of Vehicles: Mechanisms and Opportunities.
    Surber C; Knie U
    Curr Probl Dermatol; 2018; 54():152-165. PubMed ID: 30130783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Emerging Role of Ionic Liquid-Based Approaches for Enhanced Skin Permeation of Bioactive Molecules: A Snapshot of the Past Couple of Years.
    Gomes A; Aguiar L; Ferraz R; Teixeira C; Gomes P
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatokinetics as an Important Tool to Assess the Bioavailability of Drugs by Topical Nanocarriers.
    Thotakura N; Kumar P; Wadhwa S; Raza K; Katare P
    Curr Drug Metab; 2017; 18(5):404-411. PubMed ID: 28266274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of allergy to food proteins in topical medicinal agents and cosmetics.
    Codreanu F; Morisset M; Cordebar V; Kanny G; Moneret-Vautrin DA
    Eur Ann Allergy Clin Immunol; 2006 Apr; 38(4):126-30. PubMed ID: 16805419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.